Introduction {#sec1}
============

Enecarbamates play an important role in the synthesis of *N*-containing heterocycles.^[@ref1]^ They behave as nucleophiles and are stable at room temperature. They are used as precursors in asymmetric reduction to generate highly substituted chiral amines.^[@cit1b]^ Consequently, numerous methods have been reported for the synthesis of enamides/enecarbamates using Cu- or Fe-catalyzed coupling reactions, Wittig reaction, and Curtius rearrangement.^[@cit1c]^ Recently, Trost et al. reported the synthesis of trisubstituted enecarbamates through a Ru-catalyzed alkene--alkyne coupling reaction.^[@cit1d]^ In most cases, enamides and enecarbamates have been prepared by the coupling of the corresponding ketones with amines, followed by acylation with acid halide and alkyl chloroformate, respectively.^[@cit1b]^ Other methods for the preparation of enamides and enecarbamates involve the coupling of amide with vinyl halide or vinyl boronic acid and the reduction of vinyl azide in the presence of an acylating agent. In spite of their wide applications,^[@cit1e],[@cit1f]^ many of these methods involve a multistep reaction sequence and limited to less substituted enamides and enecarbamates. Furthermore, there are no reports on the synthesis of enecarbamates through an oxidative N--N bond cleavage strategy.

Recently, transition-metal-catalyzed regioselective C--H annulations through hydroarylation reactions of aromatic systems with alkynes have been extensively explored to generate substituted alkenes.^[@ref2]^ In particular, Rh(III)-catalyzed redox-neutral C--H annulations by N--O and N--N cleavage reactions are versatile to produce heteroatom-containing compounds.^[@ref3]^ However, Ru(II)-catalyzed redox-neutral C--H bond functionalization reactions by N--N and N--O bond cleavage are scarce.^[@ref4]^ In addition, Ru is cheaper compared to Rh. Therefore, there is a need to develop Ru-catalyzed redox-neutral C--H annulations. Consequently, Lu et al. reported an elegant strategy to prepare *ortho*-hydroxyphenyl-substituted enamides from *N*-phenoxyacetamide with alkynes by Rh(III)-catalyzed redox-neutral C--H bond activation.^[@ref5]^ Inspired by this methodology, we were interested to develop a Ru(II)-catalyzed redox-neutral C--H bond hydroarylation and N--N bond cleavage strategy, which provides a direct access to enecarbamates and trisubstituted alkenes.

Results and Discussion {#sec2}
======================

Following our interest in C--H bond functionalization,^[@ref6]^ we herein report a new strategy for the synthesis of enecarbamate derivatives through a C--C and C--N bond formation by a sequential hydroarylation and N--N bond cleavage. Initially, we attempted the reaction of dimethyl 1-(3,4-dimethylphenyl)hydrazine-1,2-dicarboxylate (**1a**) with but-1-yn-1-ylbenzene (**2a**) in the presence of \[Ru(*p*-cymene)Cl~2~\]~2~ (5 mol %) in trifluoroethanol at 90 °C ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry a). In the absence of additive, no product formation was observed. By the addition of 0.5 equiv of NaOAc, the desired product **3a** was obtained in 65% yield after 12 h ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry b). By increasing the amount of NaOAc to stoichiometric, the yield was increased to 80% ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry c). To optimize the conditions, further reactions were performed under diverse conditions. By changing the additive to CsOAc, the yield was decreased to 60% ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry d). By performing the reaction in hexafluoro-2-propanol, the yield was further diminished to 20% ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry e). Similarly, the yield was very poor (10%) when Cu(OAc)~2~·H~2~O was used as an additive ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry f). To our surprise, the product **4a** was formed in 35% yield when methanol was used as a solvent ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry g). Similarly, the product **4a** was obtained exclusively in dioxane and *t*-AmOH ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries h--j). The reaction did not proceed in the presence of other additives such as AgOAc and PhI(OAc)~2~ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries k and l). Other metals such as \[Cp\*RhCl~2~\]~2~, \[Cp\*IrCl~2~\]~2~, and Pd(OAc)~2~ failed to give the product ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries m--o). In the case of unsymmetrical alkynes such as 1-phenyl-1-propyne, 1-phenyl-1-butyne, and 1-phenyl-1-hexyne, the reaction proceeds in a highly regio- and stereoselective manner, wherein the alkyl-group-substituted carbon of the alkyne inserted at the ortho position of arylhydrazine-1,2-dicarboxylate.^[@cit3v],[@cit3w]^

###### Catalyst Study[a](#t1fn1){ref-type="table-fn"}

![](ao-2018-01118y_0001){#fx1}

                                                                                 yield (%)[b](#t1fn2){ref-type="table-fn"}   
  --- ---------------------------- ------------------------- ------------- ----- ------------------------------------------- ----
  a   \[Ru(*p*-cymene)Cl~2~\]~2~                             TFE           90    0                                           0
  b   \[Ru(*p*-cymene)Cl~2~\]~2~   NaOAc (0.5)               TFE           90    65                                          0
  c   \[Ru(*p*-cymene)Cl~2~\]~2~   NaOAc (1.0)               TFE           90    80                                          0
  d   \[Ru(*p*-cymene)Cl~2~\]~2~   CsOAc (1.0)               TFE           90    60                                          0
  e   \[Ru(*p*-cymene)Cl~2~\]~2~   NaOAc (1.0)               HFIP          90    20                                          0
  f   \[Ru(*p*-cymene)Cl~2~\]~2~   Cu(OAc)~2~·H~2~O (1.5)    TFE           90    10                                          0
  g   \[Ru(*p*-cymene)Cl~2~\]~2~   NaOAc (1.5)               MeOH          70    0                                           35
  h   \[Ru(*p*-cymene)Cl~2~\]~2~   Cu(OAc)~2~·H~2~O, (1.2)   1,4-dioxane   110   0                                           38
  i   \[Ru(*p*-cymene)Cl~2~\]~2~   Cu(OAc)~2~·H~2~O (1.5)    1,4-dioxane   110   0                                           42
  j   \[Ru(*p*-cymene)Cl~2~\]~2~   Cu(OAc)~2~·H~2~O (1.5)    *t*-AmOH      110   0                                           15
  k   \[Ru(*p*-cymene)Cl~2~\]~2~   AgOAc (1.0)               TFE           90    0                                           0
  l   \[Ru(*p*-cymene)Cl~2~\]~2~   PhI(OAc)~2~ (1.0)         TFE           90    0                                           0
  m   \[Cp\*RhCl~2~\]~2~           NaOAc (1.0)               TFE           80    0                                           0
  n   \[Cp\*IrCl~2~\]~2~           NaOAc (1.0)               TFE           80    0                                           0
  o   Pd(OAc)~2~                   AgOAc (1.0)               TFA           90    0                                           0

Reaction conditions for **3a**: **1a** (100 mg, 1.0 equiv), **2a** (1.5 equiv), NaOAc (1.0 equiv), \[Ru(*p*-cymene)Cl~2~\]~2~ (5 mol %), TFE (4 mL), 90 °C, 12 h. Reaction conditions for **4a**: **1a** (100 mg, 1.0 equiv), **2a** (1.5 equiv), Cu(OAc)~2~·H~2~O (1.5 equiv), \[Ru(*p*-cymene)Cl~2~\]~2~ (5 mol %), 1,4-dioxane (4 mL), 110 °C, 12 h.

Yield refers to pure products after column chromatography.

Inspired by the above results, we examined the scope of this process using a diverse range of aryl hydrazides and internal alkynes, and the results are presented in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. Interestingly, various aryl hydrazides such as methyl, methoxy, and bromo derivatives participated well in this reaction. The reaction did not proceed with electron-deficient aryl hydrazides such as nitro and cyano derivatives. Likewise, alkynes also had shown effect on the conversion. The unsymmetrical alkynes such as 1-phenyl-1-propyne, 1-phenyl-1-butyne, and 1-phenyl-1-hexyne participated in this reaction. Among them, 1-phenyl-1-hexyne and 1-phenyl-1-butyne gave the product in good yields ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries **3a**--**e**) compared with 1-phenyl-1-propyne ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entry **3f**). The reaction was also successful with symmetrical alkynes such as diphenylacetylene, 1,2-bis(4-methoxyphenyl)ethyne, and hex-3-yne ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries **3g**--**n**). However, the product was obtained in low yield in the case of hex-3-yne ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, entries **3g** and **3h**).

###### Preparation of Enecarbamates[a](#t2fn1){ref-type="table-fn"}

![](ao-2018-01118y_0006){#fx2}

Yield refers to pure products after column chromatography.

The structure of product **3b** was established by a single-crystal X-ray diffraction study ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref7]^

![ORTEP diagram of **3b**.](ao-2018-01118y_0005){#fig1}

Next, we study the scope of simple hydroarylation of alkynes, and the results are presented in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}. Interestingly, substituted aryl hydrazides such as 3,4-dimethyl, 4-methyl, 4-methoxy, 4-bromo, and 3-bromo derivatives afforded the product **4** comparatively in good yields than unsubstituted hydrazides. Likewise, alkynes also had shown some effect on the conversion. For example, 1-phenyl-1-hexyne gave the product in relatively good yields ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, entries **4b**--**g**) than 1-phenyl-1-butyne and 1-phenyl-1-propyne ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, entries **4a** and **4h**--**l**). However, symmetrical alkynes such as hex-3-yne failed to give the product, whereas diphenylacetylene gave the product as an inseparable mixture.

###### Hydroarylation of Alkynes[a](#t3fn1){ref-type="table-fn"}^,^[b](#t3fn2){ref-type="table-fn"}

![](ao-2018-01118y_0002){#fx3}

Yield refers to pure products after column chromatography.

The amount of recovered starting material is given in parenthesis.

The structure of **4g** was established by a single-crystal X-ray diffraction study ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}).^[@ref7]^

![ORTEP diagram of **4g**.](ao-2018-01118y_0007){#fig2}

On the basis of literature precedents,^[@ref5]^ we proposed a plausible reaction mechanism, which is shown in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}. The active Ru(II) acetate reacts with the NH group of aryl hydrazide to give the Ru(II) amido complex **A**, which undergoes *ortho*-metallation to give the metallacycle **B**. A subsequent alkyne insertion resulted in the formation of intermediate **C**. Reductive elimination of **C** would give the intermediate **D** and Ru(0) species. Ru(0) is reoxidized to Ru(II) during the cleavage of the cyclic N--N bond. Protodemetallation of intermediate **E** would give the product **3**. The simple hydroarylated product **4** was obtained by protonolysis of intermediate **C**.

![Plausible Reaction Pathway](ao-2018-01118y_0003){#sch1}

Conclusions {#sec3}
===========

In summary, we have developed a Ru(II)-catalyzed redox-neutral C--H bond activation for the synthesis of highly substituted enecarbamates and trisubstituted alkenes through a sequential hydroarylation and N--N bond cleavage of aryl hydrazides. These trisubstituted alkenes are very useful intermediates for the synthesis of biologically relevant cinnolines and indazoles.

Experimental Section {#sec4}
====================

General {#sec4.1}
-------

^1^H NMR spectra were recorded at 400 and 500 MHz and ^13^C NMR at 126 and 101 MHz. Tetramethylsilane was used as internal standard (δ = 0) for ^1^H NMR spectra, and the values are reported as follows: chemical shift as δ in ppm; multiplicity as s = singlet, d = doublet, t = triplet, q = quartet, and m = multiplet; and the coupling constants in Hz. For ^13^C NMR, CDCl~3~ (δ = 77.00) was used as the internal standard and spectra were obtained with complete proton decoupling. HRMS data were obtained using ESI ionization. Melting points were measured on a micro melting point apparatus.

Preparation of Starting Materials {#sec4.2}
---------------------------------

Substrate 1 was prepared according to known procedures.^[@cit6a]^

### Typical Procedure for the Synthesis of Enecarbamate (**3**) {#sec4.2.1}

To a stirred mixture of dimethyl 1-(3,4-dimethylphenyl)hydrazine-1,2-dicarboxylate (100 mg, 1.0 equiv) and alkyne (1.5 equiv) in trifluoroethanol (6 mL) were added sodium acetate (1.0 equiv) and \[Ru(*p*-cymene)Cl~2~\]~2~ (5.0 mol %) at 25 °C. The resulting mixture was stirred at 90 °C overnight in a sealed tube. After completion, the mixture was filtered with dichloromethane. Removal of the solvent followed by purification on silica gel using a gradient mixture of ethyl acetate/hexane as eluent gave the product **3**.

### Typical Procedure for the Synthesis of Trisubstituted Alkene (**4**) {#sec4.2.2}

To a solution of dimethyl 1-(3,4-dimethylphenyl)hydrazine-1,2-dicarboxylate (100 mg, 1.0 equiv) in dry dioxane were added copper(II) acetate.monohydrate (1.5 equiv) and \[Ru(*p*-cymene)Cl~2~\]~2~ (5.0 mol %). The resulting solution was degassed under Argon for 30 min, and then alkyne (1.5 equiv) was added. The reaction mixture was stirred at 110 °C for 12 h. After completion, the mixture was filtered with dichloromethane. Removal of the solvent followed by purification on silica gel using a gradient mixture of ethyl acetate/hexane as eluent gave the product **4**.

### Characterization Data for the Products (**3a**--**n** and **4a**--**l**) {#sec4.2.3}

#### (*Z*)-(2-(1-((Methoxycarbonyl)amino)-1-phenylbut-1-en-2-yl)-4,5-dimethylphenyl)carbamate (**3a**) {#sec4.2.3.1}

White solid, 121 mg, yield 80%, mp 138--140 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.77 (s, 1H), 7.44--7.31 (m, 5H), 6.88--6.77 (m, 2H), 6.00 (s, 1H), 3.74 (s, 3H), 3.47 (s, 3H), 2.35--2.20 (m, 8H), 0.91 (t, *J* = 7.4 Hz, 3H). ^13^C NMR (126 MHz, CDCl~3~) δ 154.6, 136.9, 136.9, 133.2, 132.9, 132.4, 129.6, 129.1, 128.6, 128.1, 128.0, 126.7, 122.2, 52.3, 52.2, 26.8, 19.9, 19.2, 13.3. HRMS: (*m*/*z*) calcd for C~22~H~27~O~4~N~2~ \[M + H\]^+^ 383.1965; found 383.1963.

#### Methyl (*Z*)-(4-Methoxy-2-(1-((methoxycarbonyl)amino)-1-phenylbut-1-en-2-yl)phenyl)carbamate (**3b**) {#sec4.2.3.2}

White solid, 119 mg, yield 78%. mp 142--144 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.77 (d, *J* = 7.8 Hz, 1H), 7.48--7.33 (m, 5H), 6.87 (dd, *J* = 8.8, 2.3 Hz, 1H), 6.79 (s, 1H), 6.67 (d, *J* = 2.3 Hz, 1H), 6.09 (s, 1H), 3.81 (s, 3H), 3.74 (s, 3H), 3.48 (s, 3H), 2.30 (q, *J* = 7.2 Hz, 2H), 0.93 (t, *J* = 7.3 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 156.4, 155.0, 154.7, 136.8, 133.1, 132.4, 130.4, 128.6, 128.3, 128.2, 128.1, 123.7, 114.5, 113.4, 55.5, 52.3, 52.3, 26.6, 13.2. HRMS: (*m*/*z*) calcd for C~21~H~24~N~2~O~5~Na \[M + Na\]^+^ 407.1577; found 407.1571.

#### Methyl (*Z*)-(2-(1-((Methoxycarbonyl)amino)-1-phenylbut-1-en-2-yl)phenyl)carbamate (**3c**) {#sec4.2.3.3}

Semi-solid, 107, yield 68%, mp 130--132 °C. ^1^H NMR (500 MHz, CDCl~3~) δ 8.02 (d, *J* = 7.9 Hz, 1H), 7.44--7.39 (m, 4H), 7.37--7.32 (m, 2H), 7.14--7.07 (m, 2H), 7.03 (s, 1H), 5.97 (s, 1H), 3.76 (s, 3H), 3.47 (s, 3H), 2.39--2.20 (m, 2H), 0.92 (t, *J* = 7.4 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 154.6, 154.45, 136.8, 135.3, 133.4, 129.8, 129.2, 128.9, 128.8, 128.6, 128.5, 128.2, 128.1, 123.9, 120.7, 52.3, 52.3, 26.7, 13.2. HRMS: (*m*/*z*) calcd for C~20~H~22~O~4~N~2~Na \[M + Na\]^+^ 377.1471; found 377.1473.

#### Methyl (*Z*)-(2-(2-((Methoxycarbonyl)amino)-5-methylphenyl)-1-phenylbut-1-en-1-yl)carbamate (**3d**) {#sec4.2.3.4}

Semi-solid, 100 mg, yield 65%, mp 130--132 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.85 (d, *J* = 8 Hz, 1H), 7.44--7.31 (m, 5H), 7.16--7.12 (m, 1H), 6.91 (s, 2H), 6.00 (s, 1H), 3.74 (s, 3H), 3.45 (s, 3H), 2.38--2.22 (m, 5H), 0.92 (t, *J* = 7.4 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 154.6, 136.8, 133.6, 133.2, 132.7, 129.7, 129.2, 129.1, 128.6, 128.4, 128.1, 128.09, 121.0, 52.3, 52.2, 26.8, 20.8, 13.2. HRMS: (*m*/*z*) calcd for C~21~H~24~O~4~N~2~Na \[M + Na\]^+^ 391.1634; found 391.1634.

#### Methyl (*Z*)-(2-(1-((Methoxycarbonyl)amino)-1-phenylhex-1-en-2-yl)-4,5-dimethylphenyl)carbamate (**3e**) {#sec4.2.3.5}

Semi-solid, 137 mg, yield 77%. ^1^H NMR (400 MHz, CDCl~3~) δ 7.77 (s, 1H), 7.46--7.30 (m, 5H), 6.87 (s, 1H), 6.85 (s, 1H), 6.01 (s, 1H), 3.74 (s, 3H), 3.47 (s, 3H), 2.29 (s, 3H), 2.26--2.13 (m, 5H), 1.32--1.24 (m, 2H), 1.22--1.15 (s, 2H), 0.77 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 154.6, 136.9, 136.8, 133.3, 132.7, 132.4, 129.5, 128.7, 128.1, 127.9, 122.2, 52.3, 51.7, 33.5, 30.8, 22.7, 19.9, 19.2, 13.7. HRMS: (*m*/*z*) calcd for C~24~H~30~O~4~N~2~Na \[M + Na\]^+^ 433.2097; found 433.2093.

#### Methyl (*Z*)-(2-(1-((Methoxycarbonyl)amino)-1-phenylprop-1-en-2-yl)-4,5-dimethylphenyl)carbamate (**3f**) {#sec4.2.3.6}

White solid, 90 mg, yield 62%, mp 120--122 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.71 (s, 1H), 7.54--7.26 (m, 5H), 6.89 (s, 1H), 6.87 (s, 1H), 6.03 (s, 1H), 3.74 (s, 3H), 3.48 (s, 3H), 2.28 (s, 3H), 2.23 (s, 3H), 1.94 (s, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 154.8, 136.9, 136.8, 133.0, 132.8, 132.0, 129.3, 129.0, 128.1, 127.9, 124.4, 122.7, 52.3, 20.70, 19.8, 19.2. HRMS: (*m*/*z*) calcd for C~21~H~24~O~4~N~2~Na \[M + Na\]^+^ 391.1628; found 391.1626.

#### Methyl (*Z*)-(2-(4-((Methoxycarbonyl)amino)hex-3-en-3-yl)-4,5-dimethylphenyl)carbamate (**3g**) {#sec4.2.3.7}

Semi-solid, 33 mg, yield 25%. ^1^H NMR (400 MHz, CDCl~3~) δ 7.77 (s, 1H), 6.73 (s, 1H), 6.65 (s, 1H), 5.68 (s, 1H), 3.73 (s, 3H), 3.57 (s, 3H), 2.83--2.55 (m, 2H), 2.33--2.26 (m, 2H), 2.26 (s, 3H), 2.20 (s, 3H), 1.13 (t, *J* = 7.4 Hz, 3H), 0.9 (t, *J* = 7.4 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 154.4, 154.2, 136.7, 135.5, 132.8, 132.0, 129.9, 126.5, 121.4, 52.2, 52.0, 25.8, 21.8, 19.8, 19.1, 13.3, 13.0. HRMS: (*m*/*z*) calcd for C~18~H~26~O~4~N~2~Na \[M + Na\]^+^ 357.1784; found 357.1784.

#### Methyl (*Z*)-(2-(4-((Methoxycarbonyl)amino)hex-3-en-3-yl)phenyl)carbamate (**3h**) {#sec4.2.3.8}

Semi-solid, 27 mg, yield 20%. ^1^H NMR (500 MHz, CDCl~3~) δ 8.03 (d, *J* = 8.1 Hz, 1H), 7.31--7.27 (m, 1H), 7.17--7.06 (m, 1H), 6.99 (dd, *J* = 7.6, 1.4 Hz, 1H), 6.81 (s, 1H), 5.62 (s, 1H), 3.75 (s, 3H), 3.57 (s, 3H), 2.8--2.54 (m, 2H), 2.41--2.23 (m, 2H), 1.15 (t, *J* = 7.4 Hz, 3H), 0.91 (t, *J* = 7.5 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 154.2, 135.8, 135.3, 129.1, 128.3, 123.6, 119.9, 52.3, 52.1, 25.6, 22.0, 13.2, 13.0. HRMS: (*m*/*z*) calcd for C~16~H~22~O~4~N~2~Na \[M + Na\]^+^ 329.1471; found. 329.1469.

#### Methyl (*Z*)-(2-(2-((Methoxycarbonyl)amino)-1,2-diphenylvinyl)4,6-dimethylphenyl)carbamate (**3i**) {#sec4.2.3.9}

White solid, 139 mg, yield 82%, mp 178--180 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.24 (d, *J* = 2.3 Hz, 2H), 7.19--7.13 (m, 4H), 7.06--7.00 (m, 4H), 6.92 (s, 1H), 6.85 (d, *J* = 2.1 Hz, 2H), 5.82 (s, 1H), 3.65 (s, 3H), 3.52 (s, 3H), 2.36 (s, 3H), 2.18 (s, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 156.0, 154.8, 140.4, 139.6, 137.5, 137.0, 136.6, 134.2, 131.4, 131.1, 130.2, 129.7, 128.7, 127.9, 127.7, 126.4, 52.5, 52.2, 21.0, 18.0. HRMS: (*m*/*z*) calcd for C~26~H~26~O~4~N~2~Na \[M + H\]^+^ 431.1965; found 431.1962.

#### Methyl (*Z*)-(4-Methoxy-2-(2((methoxycarbonyl)amino)-1,2-diphenylvinyl)phenyl)carbamate (**3j**) {#sec4.2.3.10}

White solid, 134 mg, yield 79%, mp 148--150 °C. ^1^H NMR (500 MHz, CDCl~3~) δ 7.56 (s, 1H), 7.30--7.26 (m, 2H), 7.22--7.18 (m, 3H), 7.07--7.04 (m, 3H), 6.92--6.85 (m, 3H), 6.85--6.81 (m, 1H), 6.46--6.33 (m, 2H), 3.80 (s, 3H), 3.64 (s, 3H), 3.53 (s, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 157.1, 155.3, 154.5, 139.2, 136.4, 134.82, 130.2, 129.8, 128.6, 128.1, 128.0, 126.81, 115.5, 114.2, 114.0, 55.6, 52.4, 52.3. HRMS: (*m*/*z*) calcd for C~25~H~24~O~5~N~2~Na \[M + Na\]^+^ 455.1577; found 455.1574.

#### Methyl (*Z*)-(2-(2-((Methoxycarbonyl)amino)-1,2-diphenylvinyl)-4,5-dimethylphenyl)carbamate (**3k**) {#sec4.2.3.11}

White solid, 133 mg, yield 78%, mp 118--120 °C. ^1^H NMR (300 MHz, CDCl~3~) δ 7.61 (s, 1H), 7.30--7.21 (m, 4H), 7.06--6.99 (m, 4H), 6.96 (s, 1H), 6.91--6.82 (m, 2H), 6.61 (s, 1H), 6.28 (s, 1H), 3.65 (s, 3H), 3.53 (s, 3H), 2.28 (s, 3H), 2.20 (s, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 154.8, 154.5, 139.7, 137.4, 136.4, 134.8, 133.1, 131.4, 130.3, 129.7, 127.9, 126.7, 52.4, 52.2, 19.8, 19.2. HRMS: (*m*/*z*) calcd for C~26~H~26~O~4~N~2~Na \[M + Na\]^+^ 453.1784; found. 453.1783.

#### Methyl (*Z*)-(2-(2-((Methoxycarbonyl)amino)-1,2-diphenylvinyl)-4-methylphenyl)carbamate (**3l**) {#sec4.2.3.12}

White solid, 134 mg, yield 77%, mp 215--217 °C. ^1^H NMR (500 MHz, CDCl~3~) δ 7.70 (s, 1H), 7.31--7.24 (m, 2H), 7.23--7.17 (m, 3H), 7.14 (d, *J* = 8.0 Hz, 1H), 7.08--7.01 (m, 4H), 6.92--6.85 (m, 2H), 6.65 (s, 1H), 6.27 (s, 1H), 3.65 (s, 3H), 3.52 (s, 3H), 2.31 (s, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 154.7, 154.5, 139.4, 136.4, 134.8, 134.4, 133.0, 130.9, 130.2, 129.7, 129.5, 128.0, 126.7, 122.6, 77.3, 77.0, 76.7, 52.4, 52.2, 20.8. HRMS: (*m*/*z*) calcd for C~25~H~24~O~4~N~2~Na \[M + Na\]^+^ 439.1628; found. 439.1625.

#### Methyl (*Z*)-(2-(5-Bromo-2-((methoxycarbonyl)amino)phenyl)-1,2-diphenylvinyl)carbamate (**3m**) {#sec4.2.3.13}

White solid, 118 mg, yield 75%, mp 200--202 °C. ^1^H NMR (500 MHz, CDCl~3~) δ 7.81 (d, *J* = 7.0 Hz, 1H), 7.44 (dd, *J* = 8.7, 2.0 Hz, 1H), 7.36--7.33 (m, 1H), 7.27--7.24 (m, 2H), 7.23--7.19 (m, 3H), 7.08--7.06 (m, 3H), 6.88--6.84 (m, 3H), 6.14 (s, 1H), 3.62 (s, 3H), 3.54 (s, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 154.4, 154.2, 138.8, 136.1, 135.3, 135.1, 132.9, 131.6, 130.2, 129.8, 128.5, 128.2, 128.1, 127.8, 127.2, 123.6, 116.8, 52.6, 52.3. HRMS: (*m*/*z*) calcd for C~24~H~21~O~4~N~2~BrNa \[M + Na\]^+^ 503.0576; found 503.0575.

#### Methyl (*Z*)-(2-(2-((Methoxycarbonyl)amino)-1,2-bis(4-methoxyphenyl)vinyl)4,6-dimethylphenyl)carbamate (**3n**) {#sec4.2.3.14}

White solid, 139 mg, yield 72%, mp 130--132 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.18 (d, *J* = 8.3 Hz, 2H), 7.10 (s, 1H), 7.02 (s, 1H), 6.88--6.53 (m, 5H), 6.66--6.55 (m, 2H), 5.85 (s, 1H), 3.77 (s, 3H), 3.71 (s, 3H), 3.63 (s, 3H), 3.52 (s, 3H), 2.35 (s, 3H), 2.18 (s, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 158.9, 157.9, 156.0, 154.9, 140.6, 137.3, 136.6, 131.2, 130.9, 128.6, 113.4, 113.2, 55.1, 52.4, 52.1, 21.0, 18.0. HRMS: (*m*/*z*) calcd for C~28~H~31~O~6~N~2~ \[M + H\]^+^ 491.2176; found 491.2191.

#### (*E*)-Dimethyl 1-(4,5-Dimethyl-2-(1-phenylbut-1-en-2-yl)phenyl)hydrazine-1,2-dicarboxylate (**4a**) {#sec4.2.3.15}

White solid, 63 mg, yield 42%, mp 102--104 °C. ^1^H NMR (500 MHz, CDCl~3~) δ 7.46--7.33 (m, 3H), 7.32--7.26 (m, 3H), 7.05 (s, 1H), 6.88 (s, 1H), 6.38 (s, 1H), 3.88--3.60 (m, 6H), 2.58--2.49 (m, 2H), 2.33--2.22 (m, 6H), 1.06--0.93 (m, 3H). ^13^C NMR (126 MHz, CDCl~3~) δ 156.4, 138.5, 137.2, 136.4, 130.7, 129.7, 128.6, 128.4, 126.9, 53.8, 52.9, 25.0, 19.5, 19.5, 13.1. HRMS: (*m*/*z*) calcd for C~22~H~27~O~4~N~2~ \[M + H\]^+^ 383.1965; found 383.1964.

#### (*E*)-Dimethyl 1-(4-Methyl-2-(1-phenylhex-1-en-2-yl)phenyl)hydrazine-1,2-dicarboxylate (**4b**) {#sec4.2.3.16}

White solid, 74 mg, yield 43%, mp 118--120 °C. ^1^H NMR (500 MHz, CDCl~3~) δ 7.52 (s, 1H), 7.41--7.34 (m, 2H), 7.28 (d, *J* = 7.5 Hz, 3H), 7.15--7.12 (m, 1H), 7.09 (s, 1H), 6.89 (s, 1H), 6.41 (s, 1H), 3.74 (s, 6H), 2.58--2.47 (m, 2H), 2.38 (s, 3H), 1.40--1.16 (m, 4H), (t, *J* = 7.1 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 156.4, 141.7, 141.4, 138.3, 137.2, 136.2, 130.1, 129.3, 128.6, 128.4, 126.9, 53.7, 52.9, 31.7, 30.7, 22.9, 21.2, 13.7. HRMS: (*m*/*z*) calcd for C~23~H~29~O~4~N~2~ \[M + H\]^+^ 397.2121; found 397.2119.

#### (*E*)-Dimethyl 1-(4-Methoxy-2-(1-phenylhex-1-en-2-yl)phenyl)hydrazine-1,2-dicarboxylate (**4c**) {#sec4.2.3.17}

White solid, 73 mg, yield 45%, mp 125--127 °C. ^1^H NMR (500 MHz, CDCl~3~) δ 7.57 (s, 1H), 7.42--7.33 (m, 2H), 7.28 (d, *J* = 7.0 Hz, 3H), 6.84 (dd, *J* = 8.5, 2.4 Hz, 2H), 6.79 (d, *J* = 2.7 Hz, 1H), 6.49--6.36 (m, 1H), 3.87--3.69 (m, 9H), 2.56--2.47 (m, 2H), 1.45--1.25 (m, 4H), 0.81 (t, *J* = 7.17 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 159.1, 156.5, 143.2, 141.5, 137.0, 131.8, 130.7, 130.2, 128.6, 128.4, 127.0, 115.2, 112.5, 55.5, 53.8, 52.9, 31.6, 30.7, 22.9, 13.8. HRMS: (*m*/*z*) calcd for C~23~H~29~O~5~N~2~ \[M + H\]^+^ 413.2071; found 413.2063.

#### (*E*)-Dimethyl 1-(4-Bromo-2-(1-phenylhex-1-en-2-yl)phenyl)hydrazine-1,2-dicarboxylate (**4d**) {#sec4.2.3.18}

White solid, 62 mg, yield 41%. mp 115--117 °C. ^1^H NMR (500 MHz, CDCl~3~) δ 7.65--7.17 (m, 8H), 6.89 (s, 1H), 6.43 (s, 1H), 3.82--3.62 (m, 6H), 2.53--2.51 (m, 2H), 1.42--1.16 (m, 4H), 0.83 (t, *J* = 6.7 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 155.9, 143.3, 141.3, 138.0, 136.7, 132.7, 130.9, 130.7, 128.6, 128.5, 127.2, 122.1, 53.9, 53.1, 24.8, 13.0. HRMS: (*m*/*z*) calcd for C~22~H~25~O~4~N~2~BrNa \[M + Na\]^+^ 483.0889; found 483.0885.

#### (*E*)-Dimethyl 1-(5-Bromo-2-(1-phenylhex-1-en-2-yl)phenyl)hydrazine-1,2-dicarboxylate (**4e**) {#sec4.2.3.19}

White solid, 59 mg, yield 39%, mp 138--140 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.81 (s, 1H), 7.47 (dd, *J* = 8.2, 2.0 Hz, 1H), 7.39--7.34 (m, 2H), 7.32--7.26 (m, 3H), 7.16 (d, *J* = 8.2 Hz, 1H), 6.87 (s, 1H), 6.41 (s, 1H), 3.76 (s, 6H), 2.55--2.48 (m, 2H), 1.33--1.23 (m, 4H), 0.82 (t, *J* = 7.0 Hz, 3H). ^13^C NMR (126 MHz, CDCl~3~) δ 155.7, 140.7, 139.3, 136.8, 132.5, 131.3, 128.6, 127.1, 120.5, 54.0, 53.1, 31.5, 30.6, 22.6, 13.7. HRMS: (*m*/*z*) calcd for C~22~H~26~O~4~N~2~Br \[M + H\]^+^ 461.1076; found 461.1072.

#### (*E*)-Dimethyl 1-(2-(1-Phenylhex-1-en-2-yl)phenyl)hydrazine-1,2-dicarboxylate (**4f**) {#sec4.2.3.20}

White solid, 63 mg, yield 37%. mp 100--102 °C. ^1^H NMR (500 MHz, CDCl~3~) δ 7.57 (s, 1H), 7.43--7.12 (m, 8H), 6.90 (s, 1H), 6.43 (s, 1H), 3.78 (s, 6H), 2.54 (s, 2H), 1.40--1.16 (m, 4H), 0.82 (t, *J* = 7.1 Hz, 3H). ^13^C NMR (126 MHz, CDCl~3~) δ 156.1, 141.7, 138.7, 137.1, 130.3, 129.7, 128.6, 128.4, 127.83, 127.0, 53.8, 53.0, 31.6, 30.6, 22.8, 13.8. HRMS: (*m*/*z*) calcd for C~22~H~27~O~4~N~2~ \[M + H\]^+^ 383.1965; found 383.1965.

#### (*E*)-Dimethyl 1-(4,5-Dimethyl-2-(1-phenylhex-1-en-2-yl)phenyl)hydrazine-1,2-dicarboxylate (**4g**) {#sec4.2.3.21}

White solid, 89 mg, yield 50%, mp 128--130 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.45--7.32 (m, 3H), 7.28--7.26 (m, 3H), 7.05 (s, 1H), 6.88 (s, 1H), 6.39 (s, 1H), 3.74 (s, 6H), 2.56--2.48 (m, 2H), 2.28 (s, 6H), 1.29--1.14 (m, 4H), 0.85 (t, *J* = 7.0 Hz, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 156.4, 141.6, 138.9, 137.3, 137.1, 136.3, 136.2, 130.7, 130.0, 128.6, 128.4, 126.8, 53.8, 52.9, 31.7, 30.7, 22.9, 19.5, 19.5, 13.8. HRMS: (*m*/*z*) calcd for C~24~H~31~O~4~N~2~ \[M + H\]^+^ 411.2278; found 411.2270.

#### (*E*)-Dimethyl 1-(4-Methoxy-2-(1-phenylbut-1-en-2-yl)phenyl)hydrazine-1,2-dicarboxylate (**4h**) {#sec4.2.3.22}

White solid, 60 mg, yield 40%, mp 120--122 °C. ^1^H NMR (500 MHz, CDCl~3~) δ 7.51 (s, 1H), 7.42--7.35 (m, 2H), 7.28 (d, *J* = 7.5 Hz, 3H), 6.95--6.82 (m, 2H), 6.81--6.79 (m, 1H), 6.41 (s, 1H), 3.84 (s, 3H), 3.82--3.69 (m, 6H), 2.58--2.50 (m, 2H), 1.00--0.94 (m, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 159.1, 156.5, 142.7, 142.3, 137.0, 131.9, 130.7, 129.8, 128.6, 128.4, 127.0, 115.1, 112.6, 55.5, 53.7, 52.9, 24.9, 13.0. HRMS: (*m*/*z*) calcd for C~21~H~25~O~5~N~2~ \[M + H\]^+^ 385.1758; found 385.1768.

#### (*E*)-Dimethyl 1-(2-(1-Phenylbut-1-en-2-yl)phenyl)hydrazine-1,2-dicarboxylate (**4i**) {#sec4.2.3.23}

White solid, 53 mg, yield 32%, mp 98--100 °C. ^1^H NMR (500 MHz, CDCl~3~) δ 7.65 (s, 1H), 7.50--7.19 (m, 8H), 6.92 (s, 1H), 6.41 (s, 1H), 3.89--3.63 (m, 6H), 2.65--2.59 (m, 2H), 1.05--0.85 (m, 3H). ^13^C NMR (101 MHz, CDCl~3~) δ 156.2, 141.32, 138.87, 137.11, 129.84, 128.68, 128.47, 127.85, 127.05, 53.84, 53.07, 24.99, 13.08. HRMS: (*m*/*z*) calcd for C~20~H~23~O~4~N~2~ \[M + H\]^+^ 355.1652; found 355.1651.

#### (*E*)-Dimethyl 1-(4,5-Dimethyl-2-(1-phenylprop-1-en-2-yl)phenyl)hydrazine-1,2-dicarboxylate (**4j**) {#sec4.2.3.24}

White solid, 58 mg, yield 40%, mp 140--142 °C. ^1^H NMR (300 MHz, CDCl~3~) δ 7.48--7.28 (m, 6H), 7.09 (s, 1H), 6.90 (s, 1H), 6.41 (s, 1H), 3.76 (m, 6H), 2.27 (m, 6H), 2.15 (s, 3H). ^13^C NMR (126 MHz, CDCl~3~) δ 156.6, 140.3, 137.2, 136.4, 136.0, 130.0, 129.8, 128.9, 128.3, 126.8, 53.8, 53.0, 19.9, 19.5, 19.4, 19.3. HRMS: (*m*/*z*) calcd for C~21~H~25~O~4~N~2~ \[M + H\]^+^ 369.1808, found 369.1807.

#### (*E*)-Dimethyl 1-(4-Methyl-2-(1-phenylprop-1-en-2-yl)phenyl)hydrazine-1,2-dicarboxylate (**4k**) {#sec4.2.3.25}

White solid, 56 mg, yield 38%, mp 138--140 °C. ^1^H NMR (400 MHz, CDCl~3~) δ 7.51 (s, 1H), 7.42--7.35 (m, 2H), 7.32 (d, *J* = 7.2 Hz, 2H), 7.29--7.25 (m, 1H), 7.13 (d, *J* = 7.8 Hz, 2H), 6.88 (s, 1H), 6.42 (s, 1H), 3.85--3.65 (m, 6H), 2.38 (s, 3H), 2.16 (s, 3H). ^13^C NMR (126 MHz, CDCl~3~) δ 156.5, 142.8, 138.5, 137.3, 136.0, 130.0, 129.6, 128.9, 128.5, 128.3, 126.9, 53.8, 53.0, 21.2, 19.2. HRMS: (*m*/*z*) calcd for C~20~H~23~O~4~N~2~ \[M + H\]^+^ 355.1672; found 355.1675.

#### (*E*)-Dimethyl 1-(4-Methoxy-2-(1-phenylprop-1-en-2-yl)phenyl)hydrazine-1,2-dicarboxylate (**4l**) {#sec4.2.3.26}

White solid, 58 mg, yield 40%, mp 108--110 °C. 1H NMR (500 MHz, CDCl~3~) δ 7.57 (s, 1H), 7.42--7.35 (m, 2H), 7.32 (d, *J* = 7.3 Hz, 2H), 7.28 (d, *J* = 7.2 Hz, 1H), 6.93--6.80 (m, 3H), 6.43 (s, 1H), 3.83 (s, 3H), 3.74 (s, 6H), 2.23--2.16 (m, 3H). ^13^C NMR (75 MHz, CDCl~3~) δ 159.2, 144.5, 137.1, 136.0, 131.5, 130.4, 130.1, 128.9, 128.4, 127.0, 114.2, 112.8, 55.5, 53.8, 53.0, 19.2. HRMS: (*m*/*z*) calcd for C~20~H~23~O~5~N~2~ \[M + H\]^+^ 371.1601; found 371.1627.
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